Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.44
+0.18 (0.89%)
Nov 13, 2026, 4:00 PM EST - Market closed
Sabra Health Care REIT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property, Plant & Equipment | 4,931 | 4,693 | 4,521 | 4,629 | 4,968 | 5,163 |
Cash & Equivalents | 36.24 | 71.54 | 60.47 | 41.29 | 49.31 | 112 |
Accounts Receivable | 101.95 | 101.41 | 104.38 | 103.29 | 117.93 | - |
Investment In Debt and Equity Securities | 70.48 | 65.35 | 61.12 | 57.85 | 51.07 | 57.06 |
Other Intangible Assets | 87.18 | 65.32 | 27.46 | 30.9 | 40.13 | 54.06 |
Loans Receivable Current | 20.82 | 33.15 | 45.87 | 43.78 | 41.33 | 33.03 |
Restricted Cash | 6.84 | 6.6 | 5.87 | 5.43 | 4.62 | 3.89 |
Trading Asset Securities | 31.41 | 3.38 | 20.38 | 18.92 | 21.48 | 3.33 |
Other Long-Term Assets | 114.63 | 118.17 | 121.8 | 136.84 | 134.96 | 231.46 |
Total Assets | 5,430 | 5,493 | 5,304 | 5,386 | 5,748 | 5,967 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Current Portion of Long-Term Debt | 0.54 | 3.43 | - | - | - | - |
Current Portion of Leases | 0.26 | 1.03 | - | - | - | - |
Long-Term Debt | 2,435 | 2,527 | 2,418 | 2,414 | 2,310 | 2,398 |
Long-Term Leases | 6.78 | 6.35 | 8.3 | 12.5 | 9.2 | - |
Accounts Payable | 83.76 | 73.17 | 67.8 | 73.78 | 83.96 | 69.16 |
Accrued Expenses | 20.3 | 9.6 | 16.1 | 16.5 | 18.2 | 21.5 |
Other Current Liabilities | 23.9 | 32.46 | 25.7 | 34.2 | 30.9 | 48.6 |
Other Long-Term Liabilities | 17.7 | 16.82 | 26.85 | 32.53 | 42.24 | 49.71 |
Total Liabilities | 2,589 | 2,670 | 2,562 | 2,584 | 2,691 | 2,587 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.62 | 2.52 | 2.38 | 2.31 | 2.31 | 2.3 |
Additional Paid-In Capital | 5,015 | 4,836 | 4,593 | 4,495 | 4,487 | 4,482 |
Distributions in Excess of Earnings | -2,201 | -2,013 | -1,875 | -1,718 | -1,452 | -1,095 |
Comprehensive Income & Other | 23.08 | -3.57 | 20.94 | 23.75 | 19.06 | -10.02 |
Total Common Equity | 2,840 | 2,822 | 2,741 | 2,803 | 3,056 | 3,380 |
Minority Interest | 1.62 | 1.95 | - | - | - | - |
Shareholders' Equity | 2,841 | 2,824 | 2,741 | 2,803 | 3,056 | 3,380 |
Total Liabilities & Equity | 5,430 | 5,493 | 5,304 | 5,386 | 5,748 | 5,967 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,443 | 2,538 | 2,426 | 2,427 | 2,516 | 2,398 |
Net Cash (Debt) | -2,375 | -2,463 | -2,345 | -2,366 | -2,445 | -2,283 |
Net Cash (Debt) Growth | - | - | - | - | - | - |
Net Cash Per Share | -9.27 | -10.07 | -9.93 | -10.17 | -10.59 | -10.42 |
Filing Date Shares Outstanding | 261.96 | 252.15 | 237.91 | 231.48 | 231.16 | 230.9 |
Total Common Shares Outstanding | 261.96 | 251.7 | 237.59 | 231.27 | 231.01 | 230.4 |
Book Value Per Share | 10.84 | 11.21 | 11.54 | 12.12 | 13.23 | 14.67 |
Tangible Book Value | 2,752 | 2,757 | 2,714 | 2,772 | 3,016 | 3,325 |
Tangible Book Value Per Share | 10.51 | 10.95 | 11.42 | 11.98 | 13.06 | 14.43 |
Land | 614.8 | 579.59 | 543.54 | 546.6 | 568.49 | 581.85 |
Buildings | 5,379 | 5,116 | 4,853 | 4,843 | 5,034 | 5,145 |